首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3篇
  免费   0篇
  国内免费   2篇
  2019年   1篇
  2018年   1篇
  2014年   1篇
  2013年   1篇
  2011年   1篇
排序方式: 共有5条查询结果,搜索用时 437 毫秒
1
1.

Background

The intra-articular implantation of mesenchymal stromal cells (MSCs) as a treatment for knee osteoarthritis (OA) is an emerging new therapy. In this study, patients with knee OA received intra-articular implantations of autologous bone marrow–derived MSCs. We sought to assess the safety and efficacy of this implantation.

Materials and Methods

This was a phase 1/2 single-center, triple-blind, randomized controlled trial (RCT) with a placebo control. The subjects consisted of patients with knee OA randomly assigned to either an intra-articular implantation of MSCs (40?×?106 cells) or 5 mL normal saline (placebo). Patients were followed up for 6 months after the implantations. The pain level and function improvements for patient-reported outcomes were assessed based on a visual analog scale (VAS), Western Ontario and McMaster Universities Arthritis Index (WOMAC) and its subscales, walking distance, painless walking distance, standing time and knee flexion compared with the placebo group at 3 and 6 months following the implantations.

Results

Overall, 43 patients (Kellgren-Lawrence grades 2, 3 and 4) were assigned to either the MSCs (n?=?19) or placebo (n?=?24) group. Patients who received MSCs experienced significantly greater improvements in WOMAC total score, WOMAC pain and physical function subscales and painless walking distance compared with patients who received placebo. There were no major adverse events attributed to the MSC therapy.

Conclusion

This randomized, triple-blind, placebo-controlled RCT demonstrated the safety and efficacy of a single intra-articular implantation of 40?×?106 autologous MSCs in patients with knee OA. Intra-articular implantation of MSCs provided significant and clinically relevant pain relief over 6 months versus placebo and could be considered a promising novel treatment for knee OA. We propose that further investigations should be conducted over an extended assessment period and with a larger cohort.  相似文献   
2.
球孢白僵菌Beauveria bassiana (Balsamo) Vuillemin是最重要的昆虫病原真菌, 广泛用于防治世界各地的多种害虫。本研究评价了球孢白僵菌9个菌株对赤拟谷盗Tribolium castaneum (Herbst)成虫的致病性。将15头赤拟谷盗成虫浸入到4个浓度 (1×106, 1×107, 1×108 和 1×109 个分生孢子/mL)的白僵菌菌株中 20 s, 14 d内每日记录成虫的死亡率。结果表明: IRAN 440C菌株对赤拟谷盗成虫的LC50最低 (5.04×107 个分生孢子/mL), IRAN 187C菌株的最高(5.05×108 个分生孢子/mL); DEBI 005菌株对赤拟谷盗成虫的LT50最短(2.88 d), DEBI 014菌株的最长(4.96 d)。根据LC50, LT50和死亡率结果得出IRAN 440C是防治这一害虫的理想菌株。  相似文献   
3.

Background

Avascular necrosis (AVN) of femoral head is a progressive bone disease due to ischemia of femoral head; patients experience pain and they can not do normal activity. There is not an effective way to treat the cause of this disease. In recent studies, treatment of this disease using pluripotent stem cell–derived mesenchyme is safe and effective, but this method needs more investigation. In this study, the safety and efficacy of CD133+ cells were evaluated as a novel method of stem cell therapy to treat AVN.

Methods

In this prospective quasi-experimental study, the participants were selected among patients with AVN who were referred to the Royan Cell Therapy Center. Autologous bone marrow–derived CD133+ cells were injected into the necrotic site of the femoral head during core decompression (CD). The Visual Analogue Scale (VAS), Harris Hip Score (HHS), Western Ontario and McMaster Universities Arthritis Index (WOMAC) and walking distance (WD) were measured before and 2, 6 and 12 months after CD.

Results

Overall, nine patients (six men and three women) were investigated in this study. Their mean age was 26 years old. All of them significantly improved in VAS, HHS, WOMAC and WD scores and they could do more activity without pain. Also, imaging findings demonstrated significant reductions in joint injuries. Significant complications were not seen in patients.

Discussion

This prospective quasi-experimental study demonstrated that, in patients with AVN, a single bone marrow–derived CD133+ cell injection into the necrotic site of the femoral head during CD is safe and effective in providing significant, clinically relevant pain relief and patients could do more activity over 2, 6 and 12 months. This pilot study suggested further clinical trials over an extended assessment period to approve bone marrow–derived CD133+ cell injection to treat AVN.  相似文献   
4.
【目的】小菜蛾Plutella xylostella (L.)是全球十字花科植物上最重要的害虫。由于施药成本的增加以及对环境的破坏性危害,抗性栽培种成为控制小菜蛾的理想选择。本研究中,鉴于对花椰菜不同栽培种的抗感性缺乏充分的了解,我们评价了几个常见栽培种的抗性以及不同植物栽培种对害虫种群增长潜力的影响。【方法】在25±2℃, RH 65%±5% 和光周期16L∶8D的室内条件下,研究了小菜蛾P. xylostella在5种花椰菜栽培种(Smilla, White cloud, Buris, Galiblanka 和Tokita)上的生命表参数。【结果】不小菜蛾幼期发育历期变化范围从Smilla上的13.44 d至Buris上的15.88 d。在Buris上观察到最高的生殖力。在Smilla上饲养的小菜蛾种群内禀增长率(0.27±0.02)和有限增长率(1.32±0.13)最高,而倍增时间最短(2.50 d)。【结论】因此,与其他栽培种相比,在伊朗南部Smilla更适合小菜蛾存活和繁殖,在条件合适和天敌缺乏时该害虫的种群能快速增长。  相似文献   
5.
The occurrence of Aphelinus paramali (Zehavi & Rosen) (Hym., Aphelinidae) was evidenced from North east Iran, in association with Aphis pomi (de Geer). This species is reported from Iran for the first time, and A. pomi is introduced as a new host for this parasitoid. Detailed morphological characters were studied with scanning electron microscopy (SEM) photographs. Also, sequences of ribosomal internal transcribed spacer 2 (ITS2) and cytochrome oxidase subunit I (COI) genes were used for determining species boundaries and comparing with other Aphelinus species. Different results were obtained in phylogenetic analysis of these two regions. Analysis of COI gene supported the closer relationship of this species with Aphelinus abdominalis. This is the first data about comprehensive characterization of a parasitic wasp using morphological characters, SEM and two‐locus information from Iran.  相似文献   
1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号